The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.
Clinical trial NCT03951051 · COMPLETED
Trial details
- NCT number
- NCT03951051
- Sponsor
- Pharmtechnology LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-06
- Primary completion
- 2019-06-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.